Cigna Group $CI Shares Sold by Running Oak Capital LLC

Key Points

• Running Oak Capital cut its stake in Cigna by 23.8% in Q4, selling 12,480 shares and leaving it with 39,869 shares valued at about $10.97 million.
• Insiders Everett Neville and Nicole S. Jones sold shares on March 2 at roughly $288.91 each, reducing their positions, while institutional investors still own about 86.99% of the company.
• Analysts are mostly positive—Cigna has a consensus "Moderate Buy" rating with a $333.11 target—after the company beat Q results (EPS $8.08 vs. $7.88), set FY2026 guidance at $30.25 EPS, and raised its quarterly dividend to $1.56.

Running Oak Capital LLC lessened its stake in Cigna Group (NYSE:CI - Free Report) by 23.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 39,869 shares of the health services provider's stock after selling 12,480 shares during the quarter. Running Oak Capital LLC's holdings in Cigna Group were worth $10,973,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Massachusetts Financial Services Co. MA boosted its holdings in shares of Cigna Group by 8.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider's stock valued at $3,249,113,000 after purchasing an additional 903,334 shares during the last quarter. Dodge & Cox boosted its holdings in shares of Cigna Group by 4.0% in the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider's stock valued at $2,682,231,000 after purchasing an additional 354,615 shares during the last quarter. Sanders Capital LLC raised its stake in shares of Cigna Group by 0.5% in the 3rd quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider's stock valued at $2,256,469,000 after acquiring an additional 35,150 shares during the period. Capital Research Global Investors raised its stake in shares of Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider's stock valued at $916,434,000 after acquiring an additional 1,855,897 shares during the period. Finally, Arrowstreet Capital Limited Partnership raised its stake in shares of Cigna Group by 7.4% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,695,620 shares of the health services provider's stock valued at $777,012,000 after acquiring an additional 186,880 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

Insider Buying and Selling at Cigna Group

In related news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares of the company's stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently commented on CI. Zacks Research raised shares of Cigna Group from a "strong sell" rating to a "hold" rating in a research note on Monday, January 5th. Guggenheim reissued a "buy" rating and issued a $318.00 target price on shares of Cigna Group in a research note on Monday, February 2nd. Sanford C. Bernstein raised shares of Cigna Group from a "market perform" rating to an "outperform" rating and raised their target price for the company from $307.00 to $358.00 in a research note on Thursday, March 12th. Wall Street Zen raised shares of Cigna Group from a "hold" rating to a "buy" rating in a research note on Saturday, February 7th. Finally, Mizuho set a $325.00 target price on shares of Cigna Group in a research note on Friday, January 9th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $333.11.

Cigna Group Stock Performance

Shares of CI stock opened at $271.55 on Monday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a market cap of $71.56 billion, a PE ratio of 12.24, a P/E/G ratio of 0.94 and a beta of 0.26. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The company's fifty day simple moving average is $276.36 and its 200-day simple moving average is $278.46.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. During the same quarter in the previous year, the firm posted $6.64 EPS. The firm's quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were paid a dividend of $1.56 per share. This is a positive change from Cigna Group's previous quarterly dividend of $1.51. The ex-dividend date of this dividend was Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group's payout ratio is presently 28.13%.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.